Kilian Schober

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 34

Top Topics

Basal Cell Carcinoma

Top Venues

Science immunology

Nature communications

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Hiltensperger, Juergen Ruland, Kilian Schober
Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. Signal transduction and targeted therapy 9 (1) (2024)
Antonio Santos-Peral, Fabian Luppa, Sebastian Goresch, Elena Nikolova, Magdalena Zaucha, Lisa Lehmann, Frank Dahlstroem, Hadi Karimzadeh, Julia Ahlfeld, Elena Winheim, Ev-Marie Schuster, Gerhard Dobler, Michael Hoelscher, Beate Mareike Kümmerer, Stefan Endres, Kilian Schober, Anne B Krug, Michael Pritsch, Giovanna Barba-Spaeth, Simon Rothenfußer
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nature communications 15 (1) (2024)
Pascal Maximilian Winterhalter, Linda Warmuth, Philipp Hilgendorf, Julius M Schütz, Sarah Dötsch, Torsten Tonn, Luka Čičin Šain, Dirk H Busch, Kilian Schober
HLA reduction of human T cells facilitates generation of immunologically multicompatible cellular products. Blood advances 8 (13) (2024)
Pascal Maximilian Winterhalter, Linda Warmuth, Philipp Hilgendorf, Julius M Schuetz, Sarah Dötsch, Torsten Tonn, Luka Čičin Šain, Dirk H Busch, Kilian Schober
HLA reduction of human T cells facilitates generation of immunologically multi-compatible cellular products. Blood advances (2024)
Antonio Santos-Peral, Fabian Luppa, Sebastian Goresch, Elena Nikolova, Magdalena Zaucha, Lisa Lehmann, Frank Dahlstroem, Hadi Karimzadeh, Julia Ahlfeld, Elena Winheim, Ev-Marie Schuster, Gerhard Dobler, Michael Hoelscher, Beate Mareike Kümmerer, Stefan Endres, Kilian Schober, Anne B Krug, Michael Pritsch, Giovanna Barba-Spaeth, Simon Rothenfußer
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nature communications 15 (1) (2024)
Vanessa Mühlgrabner, Timo Peters, Rubí M-H Velasco Cárdenas, Benjamin Salzer, Janett Göhring, Angelika Plach, Maria Höhrhan, Iago Doel Perez, Vasco Dos Reis Gonçalves, Jesús Siller Farfán, Manfred Lehner, Hannes Stockinger, Wolfgang W A Schamel, Kilian Schober, Dirk H Busch, Michael Hudecek, Omer Dushek, Susana Minguet, René Platzer, Johannes B Huppa
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation. Science advances 10 (36) (2024)
Vanessa Mühlgrabner, Timo Peters, Rubí M-H Velasco Cárdenas, Benjamin Salzer, Janett Göhring, Angelika Plach, Maria Höhrhan, Iago Doel Perez, Vasco Dos Reis Gonçalves, Jesús Siller Farfán, Manfred Lehner, Hannes Stockinger, Wolfgang W A Schamel, Kilian Schober, Dirk H Busch, Michael Hudecek, Omer Dushek, Susana Minguet, René Platzer, Johannes B Huppa
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation. Science advances 10 (36) (2024)
Michael Hiltensperger, Juergen Ruland, Kilian Schober
Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. Signal transduction and targeted therapy 9 (1) (2024)
Pascal Maximilian Winterhalter, Linda Warmuth, Philipp Hilgendorf, Julius M Schütz, Sarah Dötsch, Torsten Tonn, Luka Čičin Šain, Dirk H Busch, Kilian Schober
HLA reduction of human T cells facilitates generation of immunologically multicompatible cellular products. Blood advances 8 (13) (2024)
Antonio Santos-Peral, Fabian Luppa, Sebastian Goresch, Elena Nikolova, Magdalena Zaucha, Lisa Lehmann, Frank Dahlstroem, Hadi Karimzadeh, Julia Ahlfeld, Elena Winheim, Ev-Marie Schuster, Gerhard Dobler, Michael Hoelscher, Beate Mareike Kümmerer, Stefan Endres, Kilian Schober, Anne B Krug, Michael Pritsch, Giovanna Barba-Spaeth, Simon Rothenfußer
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nature communications 15 (1) (2024)
Pascal Maximilian Winterhalter, Linda Warmuth, Philipp Hilgendorf, Julius M Schütz, Sarah Dötsch, Torsten Tonn, Luka Čičin Šain, Dirk H Busch, Kilian Schober
HLA reduction of human T cells facilitates generation of immunologically multicompatible cellular products. Blood advances 8 (13) (2024)
Antonio Santos-Peral, Fabian Luppa, Sebastian Goresch, Elena Nikolova, Magdalena Zaucha, Lisa Lehmann, Frank Dahlstroem, Hadi Karimzadeh, Julia Ahlfeld, Elena Winheim, Ev-Marie Schuster, Gerhard Dobler, Michael Hoelscher, Beate Mareike Kümmerer, Stefan Endres, Kilian Schober, Anne B Krug, Michael Pritsch, Giovanna Barba-Spaeth, Simon Rothenfußer
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nature communications 15 (1) (2024)
Michael Hiltensperger, Juergen Ruland, Kilian Schober
Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. Signal transduction and targeted therapy 9 (1) (2024)
Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong, George Liam Ssebyatika, Thomas Krey, Valeria Falcone, Christine Schülein, Antonia Sophia Peter, Krystelle Nganou-Makamdop, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science immunology 8 (79) (2023)
Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong, George Liam Ssebyatika, Thomas Krey, Valeria Falcone, Christine Schülein, Antonia Sophia Peter, Krystelle Nganou-Makamdop, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science immunology 8 (79) (2023)
Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong, George Liam Ssebyatika, Thomas Krey, Valeria Falcone, Christine Schülein, Antonia Sophia Peter, Krystelle Nganou-Makamdop, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science immunology 8 (79) (2023)
Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong, George Liam Ssebyatika, Thomas Krey, Valeria Falcone, Christine Schülein, Antonia Sophia Peter, Krystelle Nganou-Makamdop, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science immunology 8 (79) (2023)
Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong, George Liam Ssebyatika, Thomas Krey, Valeria Falcone, Christine Schülein, Antonia Sophia Peter, Krystelle Nganou-Makamdop, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science immunology 8 (79) (2023)
Simon P Fraessle, Claudia Tschulik, Manuel Effenberger, Vlad Cletiu, Maria Gerget, Kilian Schober, Dirk H Busch, Lothar Germeroth, Christian Stemberger, Mateusz P Poltorak
Activation-inducible CAR expression enables precise control over engineered CAR T cell function. Communications biology 6 (1) (2023)
Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong, George Liam Ssebyatika, Thomas Krey, Valeria Falcone, Christine Schülein, Antonia Sophia Peter, Krystelle Nganou-Makamdop, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science immunology (2022)
Anna Purcarea, Sebastian Jarosch, Jack Barton, Simon Grassmann, Ludwig Pachmayr, Elvira D'Ippolito, Monika Hammel, Anna Hochholzer, Karolin I Wagner, Joost H van den Berg, Veit R Buchholz, John B A G Haanen, Dirk H Busch, Kilian Schober
Signatures of recent activation identify a circulating T cell compartment containing tumor-specific antigen receptors with high avidity. Science immunology 7 (74) (2022)
Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, Monika Wytopil, Stephanie Beileke, Simon Schäfer, Jahn Zhong, George Liam Ssebyatika, Thomas Krey, Valeria Falcone, Christine Schülein, Antonia Sophia Peter, Krystelle Nganou-Makamdop, Hartmut Hengel, Jürgen Held, Christian Bogdan, Klaus Überla, Kilian Schober, Thomas H Winkler, Matthias Tenbusch
Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Science immunology (2022)
David S Fischer, Meshal Ansari, Karolin I Wagner, Sebastian Jarosch, Yiqi Huang, Christoph H Mayr, Maximilian Strunz, Niklas J Lang, Elvira D'Ippolito, Monika Hammel, Laura Mateyka, Simone Weber, Lisa S Wolff, Klaus Witter, Isis E Fernandez, Gabriela Leuschner, Katrin Milger, Marion Frankenberger, Lorenz Nowak, Katharina Heinig-Menhard, Ina Koch, Mircea G Stoleriu, Anne Hilgendorff, Jürgen Behr, Andreas Pichlmair, Benjamin Schubert, Fabian Joachim Theis, Dirk H Busch, Herbert B Schiller, Kilian Schober
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'. Nature communications 12 (1) (2021)
Michael Hiltensperger, Eduardo Beltrán, Ravi Kant, Sofia Tyystjärvi, Gildas Lepennetier, Helena Domínguez Moreno, Isabel J Bauer, Simon Grassmann, Sebastian Jarosch, Kilian Schober, Veit R Buchholz, Selin Kenet, Christiane Gasperi, Rupert Öllinger, Roland Rad, Andreas Muschaweckh, Christopher Sie, Lilian Aly, Benjamin Knier, Garima Garg, Ali M Afzali, Lisa Ann Gerdes, Tania Kümpfel, Soeren Franzenburg, Naoto Kawakami, Bernhard Hemmer, Dirk H Busch, Thomas Misgeld, Klaus Dornmair, Thomas Korn
Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity. Nature immunology 22 (7) (2021)
Jürgen Held, Jan Esse, Koray Tascilar, Philipp Steininger, Kilian Schober, Pascal Irrgang, Rayya Alsalameh, Matthias Tenbusch, Christof Seggewies, Christian Bogdan
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines 9 (10) (2021)
Kilian Schober, Thomas R Müller, Dirk H Busch
Orthotopic T-Cell Receptor Replacement-An "Enabler" for TCR-Based Therapies. Cells 9 (6) (2020)
Thomas R Müller, Corinna Schuler, Monika Hammel, Amelie Köhler, Sabrina Jutz, Judith Leitner, Kilian Schober, Dirk H Busch, Peter Steinberger
A T-cell reporter platform for high-throughput and reliable investigation of TCR function and biology. Clinical & translational immunology 9 (11) (2020)
Simon Grassmann, Lorenz Leopold Mihatsch, Jonas Mir, Atefeh Kazeroonian, Roza Rahimi, Sophie Flommersfeld, Kilian Schober, Inge Hensel, Justin Leube, Ludwig O Pachmayr, Lorenz Kretschmer, Qin Zhang, Adrien Jolly, M Zeeshan Chaudhry, Matthias Schiemann, Luka Cicin-Sain, Thomas Höfer, Dirk H Busch, Michael Flossdorf, Veit R Buchholz
Early emergence of T central memory precursors programs clonal dominance during chronic viral infection. Nature immunology 21 (12) (2020)
Kilian Schober, Florian Voit, Simon Grassmann, Thomas R Müller, Joel Eggert, Sebastian Jarosch, Bianca Weißbrich, Patrick Hoffmann, Lisa Borkner, Enzo Nio, Lorenzo Fanchi, Christopher R Clouser, Aditya Radhakrishnan, Lorenz Mihatsch, Philipp Lückemeier, Justin Leube, Georg Dössinger, Ludger Klein, Michael Neuenhahn, Jennifer D Oduro, Luka Cicin-Sain, Veit R Buchholz, Dirk H Busch
Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection. Nature immunology 21 (4) (2020)
Kilian Schober, Pim Fuchs, Jonas Mir, Monika Hammel, Lorenzo Fanchi, Michael Flossdorf, Dirk H Busch
The CMV-Specific CD8+ T Cell Response Is Dominated by Supra-Public Clonotypes with High Generation Probabilities. Pathogens (Basel, Switzerland) 9 (8) (2020)
Manuel Effenberger, Andreas Stengl, Kilian Schober, Maria Gerget, Maximilian Kampick, Thomas R Müller, Dominik Schumacher, Jonas Helma, Heinrich Leonhardt, Dirk H Busch
FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC Multimers. Journal of immunology (Baltimore, Md. : 1950) 202 (7) (2019)
Kilian Schober, Thomas R Müller, Füsun Gökmen, Simon Grassmann, Manuel Effenberger, Mateusz Poltorak, Christian Stemberger, Kathrin Schumann, Theodore L Roth, Alexander Marson, Dirk H Busch
Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function. Nature biomedical engineering 3 (12) (2019)
Elvira D'Ippolito, Kilian Schober, Magdalena Nauerth, Dirk H Busch
T cell engineering for adoptive T cell therapy: safety and receptor avidity. Cancer immunology, immunotherapy : CII 68 (10) (2019)
Michaela C Baldauf, Julia S Gerke, Andreas Kirschner, Franziska Blaeschke, Manuel Effenberger, Kilian Schober, Rebeca Alba Rubio, Takayuki Kanaseki, Merve Meryem Kıran, Marlene Dallmayer, Julian Musa, Nurset Akpolat, Ayse Nur Akatlı, Fernando Colonna Rosman, Ozlem Isiksacan Ozen, Shintaro Sugita, Tadashi Hasegawa, Haruhiko Sugimura, Daniel Baumhoer, Maximilian Martin Ludwig Knott, Giuseppina Sannino, Aruna Marchetto, Jing Li, Dirk H Busch, Tobias Feuchtinger, Shunya Ohmura, Martin F Orth, Uwe Thiel, Thomas Kirchner, Thomas G P Grünewald
Systematic identification of cancer-specific MHC-binding peptides with RAVEN. Oncoimmunology 7 (9) (2018)